Clinical Trial Update: A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of canagliflozin on renal endpoints in adults with type 2 diabetes and albuminuria; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2, Albuminuria | Phase 4 | Status: COMPLETED | Results posted: 2018-12-11